OQROGet OQRO Pro
Insider trade

Cytokinetics (CYTK)Director sold ~$769K

Wendall Wierenga, Director at Cytokinetics, sold ~$769K of Cytokinetics shares.

~$769K
Approx. value · 20K sh @ $38.46
25K
Holds after · shares reported
Traded
Apr 21, 2025
Filed
Apr 21, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 3, 2025Insider · 3 peopleInsiders: 3 sales (~$528K)
  2. Mar 4, 2025Insider · 2 peopleInsiders: 2 sales (~$123K)
  3. Mar 5, 2025InsiderCEO sold ~$1.08M of CYTK shares in the open market
  4. Mar 6, 2025Insider · 3 peopleInsiders: 3 sales (~$1.2M)
  5. Mar 13, 2025InsiderOfficer sold ~$1.17M of CYTK shares in the open market
  6. Mar 14, 2025InsiderOfficer sold ~$4.5K of CYTK shares in the open market
  7. Mar 17, 2025Insider · 3 peopleInsiders: 5 sales (~$2.9M)
  8. Mar 18, 2025InsiderOfficer sold ~$87K of CYTK shares in the open market
  9. Mar 31, 2025InsiderCEO sold ~$611K of CYTK shares in the open market
  10. Apr 3, 2025InsiderDirector sold ~$18K of CYTK shares in the open market
  11. Apr 7, 2025InsiderOfficer sold ~$103K of CYTK shares in the open market
  12. Apr 8, 2025InsiderOfficer sold ~$72K of CYTK shares in the open market
  13. Apr 10, 2025InsiderCEO sold ~$184K of CYTK shares in the open market
  14. Apr 15, 2025InsiderDirector sold ~$123K of CYTK shares in the open market
  15. Apr 21, 2025 · this disclosureInsiderDirector sold ~$769K of CYTK shares in the open market

What came next

  1. Apr 22, 2025InsiderOfficer sold ~$76K of CYTK shares in the open market
  2. Apr 29, 2025InsiderCEO sold ~$205K of CYTK shares in the open market
  3. May 5, 2025InsiderOfficer sold ~$147K of CYTK shares in the open market
  4. May 6, 2025InsiderOfficer sold ~$70K of CYTK shares in the open market
  5. May 15, 2025InsiderDirector sold ~$43K of CYTK shares in the open market
  6. May 16, 2025InsiderCEO sold ~$155K of CYTK shares in the open market
  7. May 20, 2025InsiderOfficer sold ~$64K of CYTK shares in the open market
  8. Jun 2, 2025InsiderCEO sold ~$156K of CYTK shares in the open market
  9. Jun 3, 2025InsiderOfficer sold ~$64K of CYTK shares in the open market
  10. Jun 5, 2025Insider · 2 peopleInsiders: 2 sales (~$394K)
  11. Jun 11, 2025CongressDisclosed purchase of CYTK — reported range $1,001 - $15,000
  12. Jun 16, 2025InsiderCEO sold ~$169K of CYTK shares in the open market
  13. Jun 17, 2025InsiderOfficer sold ~$66K of CYTK shares in the open market
  14. Jun 17, 2025CongressDisclosed sale of CYTK — reported range $1,001 - $15,000
  15. Jul 1, 2025InsiderCEO sold ~$168K of CYTK shares in the open market
  16. Jul 8, 2025InsiderOfficer sold ~$68K of CYTK shares in the open market
  17. Jul 14, 2025InsiderCEO sold ~$191K of CYTK shares in the open market
  18. Jul 22, 2025InsiderOfficer sold ~$75K of CYTK shares in the open market
  19. Jul 29, 2025InsiderCEO sold ~$182K of CYTK shares in the open market
  20. Aug 5, 2025InsiderOfficer sold ~$73K of CYTK shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cytokinetics

For Cytokinetics, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 11 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CYTK page.

Other recent filings by Wendall Wierenga, Director

The full history of Wendall Wierenga, Director is on the profile page.

How this filing works

Other disclosures at Cytokinetics

Everything OQRO holds on this company is on its CYTK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data